Société de Therapeutique Marocaine S.A. (CBSE:SOT)

Morocco flag Morocco · Delayed Price · Currency is MAD
360.00
-6.45 (-1.76%)
At close: Jul 17, 2026
Market Cap13.79B +16.6%
Revenue (ttm)3.23B +14.6%
Net Income385.53M +22.3%
EPS10.14 +15.7%
Shares Out 38.31M
PE Ratio35.52
Forward PEn/a
Dividend6.60 (1.83%)
Ex-Dividend DateJul 1, 2026
Volume572
Open365.00
Previous Close366.45
Day's Range356.05 - 365.95
52-Week Range304.00 - 395.00
Beta0.04
Analystsn/a
Price Targetn/a
Earnings DateJul 31, 2026

About CBSE:SOT

Société de Therapeutique Marocaine S.A., a pharmaceutical company, engages in the manufacturing of licensed medicines in Morocco. It offers products in various therapeutic areas, such as allergology, oncology, cardiology, dental, dermatology, endocrinology, gastroenterology, gynecology, ophthalmology, ENT, pediatric, pulmonology, reanimation, rheumatology, central nervous system (CNS), and urology, as well as antibiotics and generics. The company also provides its products in various forms, including tablets, capsules, pouches, syrups, suspensi... [Read more]

Industry Pharmaceutical Preparations
Founded 1976
Employees 1,271
Stock Exchange Casablanca Stock Exchange
Ticker Symbol SOT
Full Company Profile

Financial Performance

In 2025, CBSE:SOT's revenue was 3.23 billion, an increase of 14.55% compared to the previous year's 2.82 billion. Earnings were 385.53 million, an increase of 22.28%.

Financial Statements